In a study comparing patients with IPD, patients with LRRK2-PD, and persons from a control group, the patients with LRRK2-PD had a 4.6-fold increased risk of leukemia compared to the IPD patients and to the control group [10]. This evidence concerns the gene LRRK2 and leukemia.